Profile_bird

Hey there! InVivoBlogEllen is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving InVivoBlogEllen's tweets.

Already using Twitter
from your phone? Click here.

Default_profile_3_bigger
InVivoBlogEllen

  1. Facet plays hard to get. Asks stockholders to say "no thank you" or something less polite to Biogen's increased offer of $17.50.
  2. @cwsampson Thanks for the shout out re the arlo post. At some point it may land me on the group W bench.
  3. The weekly deals round-up courtesy of IVB.You can get anything you want at In Vivo Blog--and Alice's restaurant.http://tinyurl.com/yaz3pv4
  4. FDA cautions docs that obesity drug Meridia comes with CV risks. Does this mark tougher guidelines for obesity drugs in development.
  5. RT @scotthensley:NPR has actor read Senate health bill in style of WC Fields, Shakespeare & Groucho. http://bit.ly/2wkjMV No Morgan Freeman?
  6. Complete response for Provenge means May 2010 PDUFA date. http://tinyurl.com/yla42kz @MHuckman says Mayday.
  7. Bet this goes over well with Carl Icahn RT @Jim_Edwards Genzyme's Termeer Got $50M in Compensation Over Last 3 Years; http://bit.ly/WWlOR
  8. The Deal names Abbott top deal-maker of 2009. Will results of IVB's Deal of the Year contest be different? Ck back soon for our nominees.
  9. Allergan calls Senate Botax on cosmetic surgery a civil rights issue. But Snowe & co. okay with furrowed brows. http://tinyurl.com/ybs89ro
  10. NICE not so nicely tells Onyx/Bayer Nexavar is too pricey. Who doubts reimbursement = new deal making hurdle? http://tinyurl.com/y86hq6c
  11. RT @PinkSheetDenise Reps Waxman, Rangel ask GAO to review #healthreform "anticipatory" drug price "gouging."
  12. Anybody struck by the irony of the ARBITER 6 trial name? It's an arbiter of what exactly? Oh, ARBITER 7. See Pink Sheet Daily for more.
  13. Wii creates a healthier generation of couch potato according to AHA study. Yes, it has come to this. http://tinyurl.com/yfuymv8
  14. Will latest GENZ contamination spark a for sale sign? Goldman Sachs calls it "significant negative surprise." That's an understatement.
  15. China moving up the pharmaceutical value chain: a shout-out to our PharmAsia News meeting. http://tinyurl.com/ydwwepv
  16. GSK/PFE HIV J/V has a name! Viva la ViiV. http://tinyurl.com/ye9f64j More tomorrow after the big press conference.
  17. Who'd thunk? Corey Goodman now an expert on ecology & sustainable development. http://tinyurl.com/yadrwb6
  18. The downsides of PPI therapy outlined in a new report. http://tinyurl.com/yl23xho
  19. Panel at BioInvestor Forum on IPO market. Lots of S-1s being written. Yeah, but will they get filed?
  20. RT @scottkirsner Heard a funny phrase today:: "He's got deep pockets but very short arms." Doesn't that describe all hc vcs today?